Ubenimex in Adult Patients With Lymphedema of The Lower Limb: a Phase 2, RAndomized, Double-blind, Placebo-controlled Study of Efficacy, Safety, and Pharmacokinetics (ULTRA)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Jan 2018
At a glance
- Drugs Ubenimex (Primary)
- Indications Lymphoedema
- Focus Therapeutic Use
- Acronyms ULTRA
- Sponsors Eiger BioPharmaceuticals
- 04 Jan 2018 According to an Eiger BioPharmaceuticals media release, enrollment in this trial has been completed and results are expected in second half of 2018.
- 28 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Nov 2017 According to an Eiger BioPharmaceuticals media release, the company anticipates to complete the trial in 2H 2018.